Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 193.00
-2.50 (-1.28%)
Aug 26, 2025, 9:53 AM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 303.22 billion as of August 25, 2025. Its market cap has increased by 222.21% in one year.
Market Cap
303.22B
Enterprise Value
293.83B
Revenue
44.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
193.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 303.22B, an increase of 3,710.11%. That is a compound annual growth rate of 291.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 303.22B | 221.33% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 163.47B |
| Bora Pharmaceuticals Co., LTD. | 92.58B |
| Lotus Pharmaceutical | 51.02B |
| Oneness Biotech | 33.91B |
| Polaris Group | 33.28B |
| Lumosa Therapeutics | 33.19B |
| Center Laboratories | 27.67B |
| Pegavision | 24.69B |